Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Glass Ceiling Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences
Life Sciences Law360 provides breaking legal news and analysis on the pharmaceutical and medical device industry. Coverage includes high-stakes litigation and policy developments that affect life sciences companies, as well as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
June 02, 2023
8th Circ. Won't Revive Heart Valve Contract Dispute
The Eighth Circuit has backed a lower court's decision to toss a contract breach suit against medical device manufacturer LivaNova over the development of a heart valve therapy, arguing that the device maker was not obligated to keep the project going after LivaNova took ownership of the project in a 2017 acquisition.
-
June 02, 2023
Judge Calls Apple's Conduct In Smartwatch Row 'Careless'
A federal judge in California on Friday ripped Apple's failure to preserve emails from a former top executive in its health division as "irresponsible and careless, and perhaps even grossly negligent," a day after a Silicon Valley medical device startup tried to draw the attention of a federal appeals court to alleged misconduct at the Patent Trial and Appeal Board.
-
June 02, 2023
Premera Joins Takeda Antitrust Litigation Over IBS Drug
Premera Blue Cross on Friday joined litigation accusing Takeda Pharmaceutical Co. of breaking antitrust law by cutting a pay-for-delay deal to keep generic versions of its anti-constipation drug Amitiza off the market for over six years.
-
June 02, 2023
BioMarin Hit With Del. Derivative Suit Over Missed Deadline
A BioMarin Pharmaceutical Inc. stockholder on Friday launched a derivative suit in Delaware's Court of Chancery, seeking a company recovery for damages caused by alleged director failures to act promptly on threats that BioMarin would miss a key regulatory deadline for a valuable new hemophilia drug prospect.
-
June 02, 2023
Care One Fired Sales Rep For Compliance Concerns, Suit Says
An ex-Care One Management sales employee has sued the hospice provider and its pharmacy partner in New Jersey state court, claiming she was passed over for a promotion to an executive role and fired for reporting allegations that the companies were violating mail order licensing regulations.
Areas of Coverage
- AGENCIES
- U.S. Consumer Product Safety Commission
- U.S. Food and Drug Administration
- U.S. Patent and Trademark Office
- U.S. International Trade Commission
- POLICY & REGULATION
- Affordable Care Act
- Federal Food, Drug, and Cosmetic Act
- Antitrust and consumer protection controls
- Drug and medical device lobbying
- State and international life sciences legislation and regulation
- ENFORCEMENT
- Drug and medical device recalls
- Drug safety actions
- Pay-for-delay investigations
- Merger reviews
- LITIGATION
- Patent disputes, including
- Abbreviated New Drug Application litigation
- Section 301 cases
- Product safety suits over drugs and medical devices, including off-label marketing and failure-to-warn claims
- Consumer litigation and class actions
- Fraud and compliance suits
- Antitrust disputes
- Labor and employment suits
- Shareholder and corporate governance disputes
- Bankruptcy proceedings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures
- Share buybacks and stock splits
- Private equity deals
- Patent-licensing agreements
- PROFILES
- Personnel moves
- Profiles of life sciences practice groups
Readership
- Life sciences lawyers at top law firms
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys in the drug, biotechnology, and medical device industries
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals